Other Stories

Pres. Moon visits SK Bioscience to encourage COVID-19 vaccine researchers Updated: 2020-10-16 06:01:42 KST

President Moon Jae-in paid a visit to SK Bioscience on Thursday to encourage researchers working on a COVID-19 vaccine.
He stressed the importance of South Korea developing its own treatments, even if the country imports them, and promised more government support.

"We need to build up experience through the development process and also lower prices. The government has injected around 183 million U.S. dollars to support the costs of clinical trials and development, and we have drawn up a budget for next year of around 244 million U.S. dollars, which is a 19% increase from this year."

The vaccine unit of SK Group has been manufacturing the antigen component of an experimental vaccine, and is entering phase one of clinical trials this month.
SK Bioscience is engaged in talks to produce vaccines for globally renowned biotech firms like Novavax.
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.